Skip to main content
Caplight Logo









Incaptek

Incaptek

Private
CourrouxHealthcare & Life Scienceshttps://incaptek.com/

Last Round

Grant

May 21, 2024

Total Funding Raised

$11,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Incaptek is a biotech and materials science company that develops advanced drug delivery systems and high-performance materials for various industries.

Sector

Healthcare & Life Sciences

Verticals

Advanced Materials, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

microencapsulationcontrolled release deliverydrug delivery systemsnanoencapsulationadvanced materialsdeep techtechnology licensingdrug-eluting coatingsmaterials sciencetargeted drug deliveryhigh performance materialsbiomaterialssmart materialscontract research organizationCROfunctional foodsnutraceuticalsaerospace materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Incaptek Comparables

Compare Incaptek with similar companies based on industry and business-model similarity.

Incaptek comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Microcaps AG
76%
Xampla
73%
MikroCaps
72%

Incaptek Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 21, 2024
AcceleratorApr 26, 2024
AcceleratorAug 2, 2023
AcceleratorMar 2, 2023

Key People

Founding team and executive leadership

Olga Fontanellaz

CEO And Co-founder

Founding Team

Incaptek Investors

Notable investors and investment history

Incaptek investors
InvestorRounds
DayOneAccelerator
Plug and Play JapanAccelerator
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 2795% MoM, from 38 to 1.1K.

  • Nov 8, 2025

    Monthly visitors grew 385% MoM, from 457 to 2.2K.

Incaptek Filings

Explore SEC and related filing metadata, where available.

Incaptek filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Incaptek's valuation, stock price, and market status.

Is Incaptek a public or private company?

Incaptek is a private company.

What is the current stock price of Incaptek?

Incaptek is a private company with no public stock price. No recent secondary market data is available.

How much is Incaptek worth (valuation)?

Valuation information for Incaptek is not publicly available.

Can I buy Incaptek stock?

Incaptek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Incaptek's last funding round?

Incaptek's most recent funding round was Grant on May 21, 2024.

Who are the main investors in Incaptek?

Key investors in Incaptek include DayOne, Plug and Play Japan, Venture Kick.

Will Incaptek IPO soon?

No public IPO plans have been announced for Incaptek.

How can I track Incaptek secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Incaptek's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCourroux
Employee Range2
Year Founded2022
Last FundingMay 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?